Performance of PTCT PTC Therapeutics | -43.2% in 12m
Compare PTCT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare PTC Therapeutics with its related Sector/Index XBI
Performance Duell PTCT vs XBI
| TimeFrame | PTCT | XBI |
|---|---|---|
| 1 Day | -2.75% | -1.52% |
| 1 Week | 2.62% | 3.45% |
| 1 Month | 31.5% | 7.71% |
| 3 Months | 27.7% | -2.11% |
| 6 Months | 61.8% | 25.51% |
| 12 Months | -43.2% | 6.37% |
| YTD | 18.0% | 1.05% |
| Rel. Perf. 1m | 2.01 | |
| Rel. Perf. 3m | 1.49 | |
| Rel. Perf. 6m | 2.33 | |
| Rel. Perf. 12m | -6.11 |
Is PTC Therapeutics a good stock to buy?
No, based on ValueRay Fundamental Analyses, PTC Therapeutics (NASDAQ:PTCT) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -55.31 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTCT as of May 2024 is 35.64. This means that PTCT is currently overvalued and has a potential downside of 7.67% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTCT as of May 2024 is 35.64. This means that PTCT is currently overvalued and has a potential downside of 7.67% (Sold with Premium).
Is PTCT a buy, sell or hold?
PTC Therapeutics has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of -43.22%.
In compare to SPDR S&P Biotech, PTCT made -49.59% less over the last 12 months. Due to the underperformance, it is recommend to sell PTCT.
In compare to SPDR S&P Biotech, PTCT made -49.59% less over the last 12 months. Due to the underperformance, it is recommend to sell PTCT.
Values above 0%: PTCT is performing better - Values below 0%: PTCT is underperforming
Compare PTCT with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.97% | 25.77% | 43.46% | -72.57% |
| US NASDAQ 100 | QQQ | 0.43% | 25.45% | 44.28% | -80.57% |
| US Dow Jones Industrial 30 | DIA | 1.26% | 25.37% | 46.28% | -65.24% |
| German DAX 40 | DBXD | 3.02% | 26.57% | 44.76% | -59.99% |
| UK FTSE 100 | ISFU | 1.12% | 21.74% | 44.89% | -58.59% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.51% | 27.02% | 58.42% | -35.55% |
| Hongkong Hang Seng | HSI | -1.11% | 8.26% | 56.71% | -37.86% |
| Japan Nikkei 225 | EXX7 | 2.25% | 32.04% | 50.26% | -55.03% |
| India NIFTY 50 | INDA | -0.49% | 27.62% | 44.17% | -71.94% |
| Brasil Bovespa | EWZ | 2.18% | 26.30% | 63.58% | -55.55% |
PTCT PTC Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.62% | 28.23% | 43.24% | -80.70% |
| Consumer Discretionary | XLY | 2.28% | 27.84% | 54.41% | -62.89% |
| Consumer Staples | XLP | 1.86% | 24.96% | 47.51% | -48.80% |
| Energy | XLE | 1.42% | 30.66% | 47.63% | -68.44% |
| Financial | XLF | 1.04% | 24.49% | 39.33% | -76.29% |
| Health Care | XLV | 0.73% | 25.86% | 46.74% | -56.72% |
| Industrial | XLI | 2.90% | 28.06% | 42.06% | -71.55% |
| Materials | XLB | 2.28% | 28.00% | 45.73% | -63.84% |
| Real Estate | XLRE | 0.11% | 23.06% | 52.11% | -53.20% |
| Technology | XLK | -0.44% | 25.02% | 45.43% | -81.53% |
| Utilities | XLU | 1.12% | 18.65% | 43.55% | -55.90% |
| Aerospace & Defense | XAR | 1.85% | 23.08% | 46.21% | -67.37% |
| Biotech | XBI | -0.83% | 23.83% | 36.24% | -49.59% |
| Homebuilder | XHB | 2.94% | 25.20% | 31.24% | -94.07% |
| Retail | XRT | 0.54% | 24.08% | 40.91% | -68.41% |
Does PTC Therapeutics outperform its market, is PTCT a Sector Leader?
No, over the last 12 months PTC Therapeutics (PTCT) made -43.22%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months PTCT made 27.73%, while XBI made -2.11%.
No, over the last 12 months PTC Therapeutics (PTCT) made -43.22%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months PTCT made 27.73%, while XBI made -2.11%.
| Period | PTCT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 31.54% | 7.71% | 5.77% |
| 3 Months | 27.73% | -2.11% | 6.32% |
| 12 Months | -43.22% | 6.37% | 29.35% |